384 related articles for article (PubMed ID: 2354439)
1. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
2. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
Yamashita T; Eto Y; Shibai H; Ogata E
Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
[TBL] [Abstract][Full Text] [Related]
3. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
5. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation.
Osborne HB; Bakke AC; Yu J
Cancer Res; 1982 Feb; 42(2):513-8. PubMed ID: 6173113
[TBL] [Abstract][Full Text] [Related]
7. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
Scher BM; Scher W; Waxman S
Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
9. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
10. Basic principles for utilizing combination differentiation agents.
Waxman S; Scher W; Scher BM
Cancer Detect Prev; 1986; 9(3-4):395-407. PubMed ID: 3527418
[TBL] [Abstract][Full Text] [Related]
11. Benzyl alcohol alters the hemoglobin phenotype of mouse erythroleukemia cells.
Scher W; Scher BM; Hellinger N; Waxman S
J Biol Regul Homeost Agents; 1989; 3(3):91-7. PubMed ID: 2483024
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaks.
Waxman S; Huang Y; Scher BM; Scher M
Biomed Pharmacother; 1992; 46(5-7):183-92. PubMed ID: 1467447
[TBL] [Abstract][Full Text] [Related]
13. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
Fibach E; Reuben RC; Rifkind RA; Marks PA
Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
[TBL] [Abstract][Full Text] [Related]
14. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
Gascoyne PR; Becker FF
J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
16. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
Richon VM; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
[TBL] [Abstract][Full Text] [Related]
17. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
Friend C; Zajac-Kaye M; Holland JG; Pogo BG
Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
[TBL] [Abstract][Full Text] [Related]
18. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells.
Ardman B; DiMambro E; Levy SB; Schwartz RS
J Immunol; 1987 Sep; 139(6):2038-43. PubMed ID: 3476672
[TBL] [Abstract][Full Text] [Related]
19. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
Lubin M
J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
[TBL] [Abstract][Full Text] [Related]
20. Changes in E2F DNA-binding activity during induced erythroid differentiation.
Richon VM; Venta-Perez G
Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
